Scibase is the developer and producer of Nevisence, the first-ever clinical tool to diagnose skin disorders using electrical impedance spectrometry (EIS). Nevisense is FDA-approved and CE-marked for skin cancer detection and is published in over 80 research projects globally across a range of skin disorders. SciBase was founded in 1998 from the Karolinska Institute in Stockholm, Sweden, and has become a rapidly-growing leader in the skin research field.